Edition:
India

Carlyle Group Inc (CG.OQ)

CG.OQ on NASDAQ Stock Exchange Global Select Market

24.07USD
23 Sep 2020
Change (% chg)

$-0.50 (-2.04%)
Prev Close
$24.57
Open
$24.57
Day's High
$24.82
Day's Low
$23.96
Volume
302,631
Avg. Vol
895,517
52-wk High
$34.95
52-wk Low
$15.21

Select another date:

Mon, Sep 14 2020

Photo

Carlyle may take $2 billion stake in retail arm of India's Reliance: Mint

BENGALURU Private equity firm Carlyle Group is looking to invest up to $2 billion in Indian conglomerate Reliance Industries' retail business, financial daily Mint reported on Monday, citing people aware of the development.

Carlyle may take $2 billion stake in retail arm of Reliance - Mint

BENGALURU Private equity firm Carlyle Group is looking to invest up to $2 billion in Indian conglomerate Reliance Industries' retail business, financial daily Mint reported on Monday, citing people aware of the development.

Carlyle leads $175 million investment round in healthcare firm Grand Rounds

Carlyle Group Inc said on Wednesday that it led a group of investors making a $175 million investment in Grand Rounds Inc, a digital healthcare company.

Carlyle buys 20% stake in Piramal Pharma businesses

U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturday.

Carlyle buys 20% stake in Piramal Pharma businesses

U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturday.

UPDATE 1-Carlyle buys 20% stake in Piramal Pharma businesses

June 27 U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturday.

Carlyle buys 20% stake in Piramal Pharma businesses

June 27 U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in India's Piramal Enterprises Ltd's pharmaceutical businesses for about $490 million, the companies said in a statement on Saturday.

BRIEF-Carlyle And Piramal Pharma Sign Agreement On A 20% Strategic Growth Investment

* THE CARLYLE GROUP LP - CARLYLE AND PIRAMAL PHARMA SIGN AGREEMENT ON A 20% STRATEGIC GROWTH INVESTMENT

BRIEF-Carlyle Group Says CAG Holdings Launches Terminal Wellness Pilot Program At LAX

* CARLYLE GROUP - CAG HOLDINGS LAUNCHES TERMINAL WELLNESS PILOT PROGRAM AT LAX Source text for Eikon: Further company coverage:

Carlyle-backed Ortho Clinical gets U.S. funding for COVID-19 tests

Private equity firm Carlyle Group Inc-backed Ortho Clinical Diagnostics said on Wednesday its COVID-19 antibody testing program received a grant of $678,000 from the U.S. Biomedical Advanced Research and Development Authority (BARDA).

Select another date: